Associated Papers
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer.
Ricci C et al.
Cancers, 2023
Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A et al.
The Journal of Clinical Endocrinology and Metabolism, 2021
Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutation.
Machens A et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research.
Belli C et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2021
Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancer.
Machens A et al.
Best Practice & Research. Clinical Endocrinology & Metabolism, 2019
Genotype-specific progression of hereditary medullary thyroid cancer.
Machens A et al.
Human Mutation, 2018
Genetic and Epigenetic of Medullary Thyroid Cancer
Khatami F et al.
Iranian Biomedical Journal, 2018
Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.
Toledo RA et al.
Endocrine-related Cancer, 2015
25425582 (PubMed )
Supplement: supp_ERC-14-0491_Supplementary_table_2.xlsx › Sheet1
Central role of RET in thyroid cancer.
Santoro M et al.
Cold Spring Harbor Perspectives in Biology, 2013
Select a paper to view details